Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil analgesic protocol for postoperative recovery after laparoscopic cholecystectomy in women
ChiCTR2600129411Phase 4Recruiting
- Sponsor
- Shaanxi 215 Hospital
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in gallbladder disease, postoperative pain and postoperative nausea and vomiting (PONV) comparing Oliceridine + TAP block with Sufentanil + TAP block (2 arms). Primary endpoint: Postoperative QoR-15 score at 24 hours. Started Aug 2026; status: recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
gallbladder diseasepostoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2600129411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129411.